Clinical Trials Browser

Phase 1/2 × Selenomethionine × Genitourinary × Clear all

NCT02535533 2026-05-06

SLM + Axitinib for Clear Cell RCC

Phase 1/2 Completed

45 enrolled 18 charts

Kidney Neoplasms

NCT05363631 2025-12-10

Seleno-L Methionine (SLM)-Axitinib-Pembrolizumab

Phase 1/2 Active not recruiting

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell